ReproUnionReproductive Medicine Across Borders
When asking young people, most envision a life with children, but reproductive challenges affect up to 25% of couples in Scandinavia. Every 8th woman never becomes a mother, and every 5th man never becomes a father.
With a new research and innovation paradigm within reproductive medicine in the Øresund Region, ReproUnion wants to meet current and future demands of preventing, managing, and treating infertility. Infertility is recognized as a disease by the WHO, but despite revolutionary developments in the techniques for assisted reproduction, the success rate is still below 30%.
ReproUnion drives fertility collaboration across borders and disciplines between academia, hospitals, and industry. Our aim is to understand the underlying reasons of infertility and to personalise and improve fertility treatment. We also work on preventive initiatives to ensure that the society and young people are equipped with the right information to make informed choices about family planning.
Find out what’s going on & stay up to date
In collaboration with scientists from 20 Universities around the world, ReproUnion colleagues at Rigshospitalet have uncovered how a gen-mutation is a reason for missing sperm cells. This is for the first time described in relation to infertility in a newly published article in the prestigious New England Journal of Medicine
In June, the message about the ReproUnion Biobank and Infertility Cohort (RUBIC) spread across Danish, Swedish and scientific media – exactly one year after RUBIC enrolled the first infertile couples!
ReproUnion supported PhD adds novel insights to how genetic and epigenetic variations influence testicular function
In her PhD Nina Mørup Nygaard researched how both common and rare genetic variants play different, but significant roles for male reproduction. She further investigated how small non-coding RNAs can serve as biomarkers for testicular cancer and her results have been covered by various publications.